Survey on the epidemiological situation, laboratory capacity and preparedness for Candidozyma (Candida) auris, 2024

The 2024 ECDC survey shows that Candidozyma (Candida) auris is rapidly emerging in Europe, with 4,012 cases reported in EU/EEA countries between 2013–2023, including 1,346 in 2023 alone, and additional cases in enlargement countries. While 10 countries have not yet detected the pathogen, others such as Spain, Italy, Greece, and Romania already face regional endemicity, often within 5–7 years of first detection. Outbreaks have also occurred in Germany, France, and Cyprus. Laboratory capacity has improved, but surveillance and preparedness remain uneven: only 25% of countries have mandatory notification and fewer than half have national surveillance systems or clear guidance on clinical and infection prevention measures. The ECDC warns that without early detection, systematic surveillance, and strong infection control, C. auris could become established across more European healthcare systems.